Immunohistochemistry in treated nephroblastoma?
Drut
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007150:Immunohistochemistry; D007680:Kidney Neoplasms / Q000378:metabolism* / Q000628:therapy*; D009392:Nephrectomy; D042582:Vascular Endothelial Growth Factor C / Q000378:metabolism*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*; D009396:Wilms Tumor / Q000378:metabolism* / Q000628:therapy*
D000970:Antineoplastic Agents; D042582:Vascular Endothelial Growth Factor C; D040301:Vascular Endothelial Growth Factor Receptor-2